Array BioPharma, Inc.
Array BioPharma achieves milestone for selection of third compound for anticancer program
Published in Lab Business Week, May 14th, 2006
The second compound was selected in January 2006, which also paid a $1 million milestone to Array. In December 2003, Array partnered the oncology portion of its MEK program, including its lead compound, ARRY-142886 (AZD6244), for co-development and commercialization with AstraZeneca. At that time, Array and AstraZeneca established a collaboration for research and development of additional clinical candidates.
MEK is a critical enzyme at the intersection of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-05-14)
More Articles from Lab Business Week
- Aethlon Medical, Inc.
Aethlon Medical submits Avian influenza treatment grant application - Allergan, Inc.
Allergan completes note offerings, redeems convertible notes due 2022 - Amarin Corp. plc
Amarin completes $4.2M financing - AspenBio Pharma, Inc.
AspenBio Pharma closes $1,428,000 private placement - Baxter Healthcare Corp.
Baxter launches grant program to promote advancement in treatment of kidney disease - BioE, Inc.
BioE appoints VP of finance and accounting - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
